- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/00 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patent holdings for IPC class C07D 513/00
Total number of patents in this class: 123
10-year publication summary
|
6
|
3
|
2
|
1
|
1
|
3
|
1
|
3
|
2
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3751 |
7 |
| Bristol-myers Squibb Company | 4880 |
6 |
| Boehringer Ingelheim International GmbH | 4642 |
3 |
| SpecGx LLC | 188 |
3 |
| Glaxo Group Limited | 4063 |
2 |
| Merck Sharp & Dohme Corp. | 2191 |
2 |
| Janssen Pharmaceutica N.V. | 3394 |
2 |
| Wyeth LLC | 659 |
2 |
| Bayer Animal Health GmbH | 219 |
2 |
| Merck Sharp & Dohme B.V. | 708 |
2 |
| Abbvie Inc. | 1800 |
2 |
| Progenics Pharmaceuticals, Inc. | 128 |
2 |
| Novartis AG | 10744 |
1 |
| F. Hoffmann-La Roche AG | 7947 |
1 |
| Samsung Display Co., Ltd. | 34907 |
1 |
| The Regents of the University of California | 19961 |
1 |
| Genentech, Inc. | 3976 |
1 |
| Merck & Co., Inc. | 319 |
1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 78 |
1 |
| Pfizer Inc. | 3371 |
1 |
| Other owners | 80 |